OUCRU Outbreak Advisory Board in the COVID-19 Pandemic in Viet Nam
Journal article
Ngo PBT. et al, (2024), Wellcome Open Research, 9, 422 - 422
Antimicrobial resistance among common bacterial pathogens in Indonesia: a systematic review
Journal article
Gach MW. et al, (2024), The Lancet Regional Health - Southeast Asia, 26, 100414 - 100414
Detection of co-infection and recombination cases with Omicron and local Delta variants of SARS-CoV-2 in Vietnam.
Journal article
Trang NT. et al, (2024), Sci Rep, 14
Clinical presentation and treatment of 2 patients with infection caused by Chromobacterium violaceum in Vietnam.
Journal article
Nam BV. et al, (2024), BMC Infect Dis, 24
Understanding hospital antimicrobial prescribing decisions and determinants of uptake of new local antimicrobial prescribing guidelines in the Laos
Journal article
Chansamouth V. et al, (2024), Wellcome Open Research, 9, 183 - 183
Antibiotic prescribing practices of medical doctors in a resource-limited setting and the influence of individual perceptions and stewardship support: a survey in three tertiary hospitals in Vietnam.
Journal article
Vu HTL. et al, (2024), JAC Antimicrob Resist, 6
Age-time-specific transmission of hand-foot-and-mouth disease enterovirus serotypes in Vietnam: A catalytic model with maternal immunity.
Journal article
Chen Y. et al, (2024), Epidemics, 46
Barriers and enablers to blood culture sampling in Indonesia, Thailand and Viet Nam: a Theoretical Domains Framework-based survey.
Journal article
Suntornsut P. et al, (2024), BMJ Open, 14
Feasibility of wearable monitors to detect heart rate variability in children with hand, foot and mouth disease.
Journal article
Nhan LNT. et al, (2024), BMC Infect Dis, 24
Emerging Enterovirus A71 Subgenogroup B5 Causing Severe Hand, Foot, and Mouth Disease, Vietnam, 2023.
Journal article
Chau NVV. et al, (2024), Emerg Infect Dis, 30, 363 - 367
Implementing the WHO AWaRe antibiotic book guidance in lower-resource settings: the case of the Lao PDR.
Journal article
Chansamouth V. et al, (2024), JAC Antimicrob Resist, 6
Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Journal article
RECOVERY Collaborative Group None., (2023), Lancet Diabetes Endocrinol, 11, 905 - 914
Evidence review and recommendations for the implementation of genomics for antimicrobial resistance surveillance: reports from an international expert group.
Journal article
Baker KS. et al, (2023), Lancet Microbe, 4, e1035 - e1039
Exploiting genomics for antimicrobial resistance surveillance at One Health interfaces.
Journal article
Muloi DM. et al, (2023), Lancet Microbe, 4, e1056 - e1062
Genomics for antimicrobial resistance surveillance to support infection prevention and control in health-care facilities.
Journal article
Jauneikaite E. et al, (2023), Lancet Microbe, 4, e1040 - e1046
Genomics for public health and international surveillance of antimicrobial resistance.
Journal article
Baker KS. et al, (2023), Lancet Microbe, 4, e1047 - e1055
Innovations in genomic antimicrobial resistance surveillance.
Journal article
Wheeler NE. et al, (2023), Lancet Microbe, 4, e1063 - e1070
Talaromycosis
Chapter
Le T. et al, (2023), Diagnosis and Treatment of Fungal Infections: Third Edition, 339 - 349
A just transition for antimicrobial resistance: planning for an equitable and sustainable future with antimicrobial resistance.
Journal article
Just Transitions for AMR Working Group None., (2023), Lancet